STAGE IVA LIVER CANCER
Clinical trials for STAGE IVA LIVER CANCER explained in plain language.
Never miss a new study
Get alerted when new STAGE IVA LIVER CANCER trials appear
Sign up with your email to follow new studies for STAGE IVA LIVER CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to boost Radiation's punch against tough GI cancers
Symptom relief OngoingThis early-phase study tested an oral drug called ropidoxuridine (IPdR) in 19 people with advanced gastrointestinal cancers that could not be cured. The goal was to find the safest dose and see if the drug could make tumor cells more sensitive to radiation therapy. The study focu…
Matched conditions: STAGE IVA LIVER CANCER
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Symptom relief
Last updated May 17, 2026 03:16 UTC
-
One-Day liver cancer treatment shows promise in early trial
Symptom relief OngoingThis early-phase study tests whether a liver cancer treatment called Y90 radioembolization can be safely done in a single session instead of the usual two-day process. The treatment uses tiny radioactive beads injected into the liver's blood supply to shrink tumors. Researchers w…
Matched conditions: STAGE IVA LIVER CANCER
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated May 11, 2026 20:38 UTC